Literature DB >> 25834496

Evaluation of cases with a preliminary diagnosis of Crimean- Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey.

Hüseyin Can Hekimoğlu1, Neşe Ateş Demirci1.   

Abstract

BACKGROUND: Crimean-Congo hemorrhagic fever (CCHF) is an endemic disease in Turkey. The clinical presentation and laboratory findings are not specific especially in cases without hemorrhagic findings.
OBJECTIVE: We aimed to evaluate CCHF cases and compare them with non-CCHF cases in terms of their characteristics during admission.
METHODS: Cases with a preliminary diagnosis of CCHF at a secondary care hospital in Kastamonu in 2013 were evaluated, retrospectively. Cases testing RNA/IgM positive were considered as CCHF. Cases testing both RNA and IgM negative were considered as non-CCHF. The two groups were then compared in terms of their clinical, laboratory and epidemiological characteristics during admission.
RESULTS: A total of 41 cases were tested and CCHF was found in 46.3% of cases. Fatality was 5.3% in CCHF cases. The frequency of tick bites and CK elevation in CCHF cases was significantly higher than non-CCHF cases (p<0.05). There were no significant differences between the two groups regarding other characteristics (p>0.05).
CONCLUSIONS: In cases with a preliminary diagnosis of CCHF, especially in cases without a history of tick bite and with normal CK levels during admission, performing tests for the differential diagnosis may be advisable without waiting for the results of tests for CCHF.

Entities:  

Keywords:  Crimean-congo hemorrhagic fever; Kastamonu; Turkey

Mesh:

Substances:

Year:  2014        PMID: 25834496      PMCID: PMC4370066          DOI: 10.4314/ahs.v14i4.15

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  32 in total

1.  Seroprevalence and risk factors of Crimean-Congo hemorrhagic fever in selected seven provinces in Turkey.

Authors:  Dilek Yagci-Caglayik; Gülay Korukluoglu; Yavuz Uyar
Journal:  J Med Virol       Date:  2013-09-13       Impact factor: 2.327

2.  The seroprevalence of Crimean-Congo haemorrhagic fever among inhabitants living in the endemic regions of Western Anatolia.

Authors:  Bulent Ertugrul; Sevin Kirdar; Ozlem Saylak Ersoy; Mevlut Ture; Nermin Erol; Barcin Ozturk; Serhan Sakarya
Journal:  Scand J Infect Dis       Date:  2011-10-22

3.  Characteristics of patients admitted to the emergency department due to tick bite.

Authors:  Ali Kemal Erenler; Fuat Kulaksiz; Hüseyin Ülger; Murat Erdem; Cem Koçak; Fatih Söylemez; Özkan Öztürk; Ahmet Baydin
Journal:  Trop Doct       Date:  2014-01-15       Impact factor: 0.731

4.  Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever.

Authors:  Saliha Bakır Ozbey; Çiğdem Kader; Ayşe Erbay; Önder Ergönül
Journal:  Vector Borne Zoonotic Dis       Date:  2014-04-01       Impact factor: 2.133

Review 5.  Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity.

Authors:  Dennis A Bente; Naomi L Forrester; Douglas M Watts; Alexander J McAuley; Chris A Whitehouse; Mike Bray
Journal:  Antiviral Res       Date:  2013-07-29       Impact factor: 5.970

6.  Crimean-Congo hemorrhagic fever virus-tick survey in endemic areas in Bulgaria.

Authors:  Ivanka Gergova; Metodi Kunchev; Bozhin Kamarinchev
Journal:  J Med Virol       Date:  2012-04       Impact factor: 2.327

Review 7.  Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries.

Authors:  Onder Ergonul
Journal:  Curr Opin Virol       Date:  2012-04       Impact factor: 7.090

Review 8.  The impact of Crimean-Congo hemorrhagic fever virus on public health.

Authors:  Marc Mertens; Katja Schmidt; Aykut Ozkul; Martin H Groschup
Journal:  Antiviral Res       Date:  2013-02-28       Impact factor: 5.970

9.  Evaluation of patients with Crimean-Congo hemorrhagic fever in Bolu, Turkey.

Authors:  A Duran; A Küçükbayrak; T Ocak; N I Hakyemez; T Taþ; M Karadađ; Z F Mengelođlu
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

10.  The seroprevalance of Crimean-Congo haemorrhagic fever in people living in the same environment with Crimean-Congo haemorrhagic fever patients in an endemic region in Turkey.

Authors:  I Koksal; G Yilmaz; F Aksoy; S Erensoy; H Aydin
Journal:  Epidemiol Infect       Date:  2013-05-21       Impact factor: 4.434

View more
  3 in total

1.  Editorial.

Authors:  James Tumwine
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Direct healthcare costs for patients hospitalized with Crimean-Congo haemorrhagic fever can be predicted by a clinical illness severity scoring system.

Authors:  Ilkay Bozkurt; Mustafa Sunbul; Hava Yilmaz; Saban Esen; Hakan Leblebicioglu; Nicholas J Beeching
Journal:  Pathog Glob Health       Date:  2016-02-25       Impact factor: 2.894

3.  Evaluation of Crimean-Congo hemorrhagic fever suspected cases admitted to a secondary care hospital in Kastamonu, Turkey between 2014-2017.

Authors:  Hasan Tahsin Gozdas
Journal:  Afr Health Sci       Date:  2019-03       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.